Earn more credits by taking our
bundled PCE HOME STUDY activities.

%%series-name%%

2020 PCE eClinic

  • Release Date: March 31, 2021
  • Expiration Date: March 30, 2022
  • Credit Hours Available: 5.00
    Pharmacology Hours for NPs: 5.00

  • Beyond Counting Sheep: New Strategies for Sleep Maintenance Insomnia
  • Reducing the Risk: Advanced Influenza Treatment Options for the 2020-2021 Season
  • Collaborative Care in the Management of Multiple Sclerosis: Where Does Primary Care Fit?
  • Traversing the Chasm: Overcoming Challenges of Obesity Management in Primary Care
  • Early Identification and Management of Rheumatoid Arthritis: The Critical Role of Primary Care
%%series-name%%

APP Oncology Bootcamp Powered by PCE

  • Release Date: March 20, 2021
  • Expiration Date: March 19, 2022
  • Credit Hours Available: 5.00
    Pharmacology Hours for NPs: 5.00

  • Integrating New Therapies Into the Treatment of Advanced Prostate Cancer
  • New Options for Advanced Renal Cell Carcinoma: Targeted and Immunotherapies
  • Updates in Advanced Pancreatic Cancer: Integrating New Therapies Into Clinical Practice
  • The Evolving Treatment Landscape for Advanced Gastric Cancer: New Data on Novel Treatment Options
  • Applying Recent Advances in Metastatic Colorectal Cancer to Improving Patient Care
%%series-name%%

Fall 2020 PCE Oncology

  • Release Date: December 16, 2020
  • Expiration Date: December 15, 2021
  • Credit Hours Available: 8.00
    Pharmacology Hours for NPs: 8.00

  • Relapsed/Refractory Multiple Myeloma: Integrating Novel Agents into the Treatment Paradigm
  • The Evolving Landscape of Prostate Cancer Management
  • Managing Patients Treated With CAR T-Cell Therapy
  • Therapeutic Advances in Metastatic HER2-Positive Breast Cancer
  • Immune Checkpoint Inhibitor Therapy: Recognition and Management of Adverse Events
  • Novel Therapies in Advanced Urothelial Cancer: Effective Management of Treatment-Related Toxicities
  • Small Cell Lung Cancer: A Changing Treatment Paradigm
  • Precision Oncology: Identifying and Treating Patients With NSCLC
%%series-name%%

PCE 2020 Clinical Reviews and Case Studies

  • Release Date: October 31, 2020
  • Expiration Date: October 30, 2021
  • Credit Hours Available: 5.00
    Pharmacology Hours for NPs: 5.00

  • The Continuum of Care in Atopic Dermatitis: Advances in Management
  • Influenza Management in the High-Risk Patient
  • Improving Glycemic and Cardiorenal Outcomes in T2DM: The Expanding Role of SGLT2 Inhibitors
  • 2020 Vision: Implementing the New ADA 2020 Guidelines for GLP-1 RAs in Clinical Practice
  • Rheumatoid Arthritis: Best Practices in Diagnosis and Management in the Era of Novel Agents
%%series-name%%

Spring 2020 PCE Symposia

  • Release Date: August 31, 2020
  • Expiration Date: August 30, 2021
  • Credit Hours Available: 7.50
    Pharmacology Hours for NPs: 7.50

  • Optimizing Outcomes in Moderate to Severe Asthma: Utilizing Biologic Therapy for Individualized Treatment
  • The Pivotal Role of Primary Care Clinicians in the Management of Heart Failure
  • Managing the Spectrum of Psoriatic Disease in Primary Care
  • Embracing New Treatment Options in the Management of Migraine Headache
  • Weighing the Options: Prevention and Management of Influenza in Patients at High Risk for Complications
  • Reducing the Burden of Endometriosis: The Role of Primary Care
  • New Options for a Common Condition: Management of Dry Eye Disease
%%series-name%%

Spring 2020 PCE Oncology

  • Release Date: August 15, 2020
  • Expiration Date: August 14, 2021
  • Credit Hours Available: 9.00
    Pharmacology Hours for NPs: 9.00

  • Optimizing the Management of Acute Myeloid Leukemia: Individualized Therapy
  • Key Updates in the Treatment of HER2-Positive Breast Cancer
  • Triple Negative Breast Cancer: Fitting New and Emerging Strategies into Patient Care
  • New Treatment Paradigms in Relapsed/Refractory Multiple Myeloma: Integrating Novel Agents Into Clinical Practice
  • Evolving Options in Metastatic Prostate Cancer
  • Raising the Bar for the Standard of Care: Advances in the Management of Advanced Renal Cell Carcinoma
  • New Horizons in Advanced Gastric Cancer: Integrating Novel Treatment Strategies into Clinical Practice
  • Maximizing the Benefits of Targeted Cancer Treatment with PI3K Inhibitors
  • Advances in Chronic Lymphocytic Leukemia: Key Elements for Today’s Clinics

Development Widget